QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai,[…]
Read moreAuthor: Stephane
SENIOR cohort : imaging the aging brain
Imaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-François Mangin, Alexandre Vignaud, Cyril[…]
Read moreAPP Ab38 Ab40 in FTD
Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audrey, Roche, Stéphane, Gény, Christian, Bennys, Karim, Labauge,[…]
Read moresAPP & Abeta in CSF
Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Audrey Gabelle,[…]
Read morePreanalytical guidelines
Preanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Roche, Y. Allory, A. Barthelaix, J.-L. Beaudeux, F.[…]
Read moreBiomarkers in CSF
Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications cliniques dans les démences A Gabelle, S. Roche &[…]
Read moreAutoantibody in CSF
Auto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal-fluid. Stéphane Roche, Yves Dauvilliers, Laurent Tiers, Carine Couderc,[…]
Read moreClinical proteomics in CSF
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roche, Audrey Gabelle & Sylvain Lehmann Proteomics[…]
Read more